Felis ISSN 2398-2950

Spironolactone

Contributor(s): Mark Rishniw

Introduction

Name

  • Spironolactone.

Class of drug

  • Potassium-sparing diuretic.

Description

Chemical name

  • 17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid-alpha-lactone.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Particularly useful in the treatment of edema associated with congestive heart failure   Heart: congestive heart failure  (when hypokalemia may potentiate digoxin toxicity) and hepatic failure   Liver: cirrhosis  (when hypokalemia can precipitate hepatic encephalopathy   Hepatic encephalopathy  ).
  • Used in combination diuretic therapy (with thiazides and furosemide).

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Pharmocokinetics

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

ACE inhibitors, eg captopril, enalapril
  • Hyperkalemia may result.

  • NSAIDs
  • Hyperkalemia may result.
  • There is an increased risk of nephrotoxicity

  • Potassium supplements
  • Hyperkalemia may result.

  • Digoxin
  • May increase half-life of digoxin.
  • The effect of digoxin may be enhanced.

with diagnostic tests

  • Electrolyte imbalances should be monitored.

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Other sources of information

  • Based onSmall Animal Formulary.Tennant, Bryn (1999) 3rd edn. Cheltenham: BSAVA.

ADDED